Full Episode
Tuesday, Feb 23
PBS NewsHour
  • Episodes
  • Podcasts
  • Subscribe
  • The Latest
  • Politics
    Politics
    • Shields and Brooks
    • Politics Monday
    • Supreme Court
  • Arts
    Arts
    • CANVAS
    • Poetry
    • Now Read This
  • Nation
    Nation
    • Supreme Court
    • Race Matters
    • Essays
    • Brief But Spectacular
  • World
    World
    • Agents for Change
  • Economy
    Economy
    • Making Sen$e
    • Paul Solman
  • Science
    Science
    • The Leading Edge
    • ScienceScope
    • Basic Research
    • Innovation and Invention
  • Health
    Health
    • Long-Term Care
  • Education
    Education
    • Teachers' Lounge
    • Student Reporting Labs
  • For Teachers
  • About
    • Feedback
    • Funders
    • Support
    • Jobs

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Nation
PBS NewsHour

Get news alerts from PBS NewsHour

Turn on desktop notifications?

Linda A. Johnson, Associated Press

  • Full Episodes
  • Podcasts
  • Subscribe
  • Live

Linda A.’s Recent Stories

Health Jan 29

Johnson & Johnson’ single-shot vaccine is 66 percent effective against COVID-19

With vaccinations off to a rocky start globally, experts had been counting on a one-dose vaccine that would stretch scarce supplies and avoid the logistics nightmare of getting people to return for boosters.

Health Oct 23

AstraZeneca, Johnson & Johnson resume U.S. tests of COVID-19 vaccines

Two drugmakers say they have the go-ahead to resuming U.S. testing of their COVID-19 vaccine candidates. Both are in the final stage of testing before the companies can seek regulatory approval.

Health Sep 23

Late-stage study of first single-shot vaccine begins in U.S.

Johnson & Johnson is beginning a huge final-stage study to try to prove if a single-dose COVID-19 vaccine can protect against the virus.

Health Aug 20

Pandemic pushes expansion of ‘hospital-at-home’ treatment

Communications technology, portable medical equipment and teams of doctors, nurses, X-ray techs and paramedics make this possible. Like telemedicine, the concept stands to become more popular with consumers hooked on home delivery and other Internet-connected conveniences.

Health Aug 19

FDA blocks much-anticipated BioMarin hemophilia gene therapy

Investors fled drug developer BioMarin in droves on Wednesday, driving shares down by a third after U.S. regulators rejected the company's potentially game-changing hemophilia A gene therapy.

Health Feb 28

FDA reports drug shortage tied to novel coronavirus outbreak

The Food and Drug Administration declined to identify the manufacturer or the product.

Nation Dec 28

Age limit now 21 across US for cigarettes, tobacco products

Anyone under 21 can no longer legally buy cigarettes, cigars or any other tobacco products in the U.S.

Politics Dec 19

New trade deal presents landmark loss for Big Pharma

To satisfy House Democrats, the Trump administration removed a provision that would have given the makers of ultra-expensive biologic drugs 10 years of protection from less-expensive knockoffs.

Economy Dec 19

Investors brace for market slowdown going into 2020 and beyond

Markets are coming off a fabulous 2019, where stocks and bonds around the world climbed in concert. But for the next year — and decade, in fact — Wall Street is telling investors to set their expectations considerably lower.

Health Nov 15

U.S. approves new drug to manage sickle cell disease, costs $85,000 to $113,000

The monthly infusion, which halves occurrences of sickle cell pain episodes, will carry a list price of roughly $85,000 to $113,000 per year, depending on dosing. Insured patients generally will pay less.

Jump to the First Page Previous Page
1 2
Next Page Jump to the Last Page

Support Provided By: Learn more

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

PBS NewsHour

© 1996 - 2021 NewsHour Productions LLC. All Rights Reserved.

Sections

  • The Latest
  • Politics
  • Arts
  • Nation
  • World
  • Economy
  • Science
  • Health
  • Education

About

  • About Us
  • TV Schedule
  • Press
  • Feedback
  • Funders
  • Support
  • Subscribe
  • NewsHour West
  • Jobs
  • Privacy

Stay Connected

  • Facebook
  • Twitter
  • YouTube
  • RSS

Subscribe to ‘Here's the Deal,’ our politics newsletter

Form error message goes here.

Thank you. Please check your inbox to confirm.

Support our journalism

Learn more about Friends of the NewsHour.

Support for NewsHour Provided By

  • BNSF Railway
  • Consumer Cellular
  • Corporation for Public Broadcasting
  • Fidelity
  • Johnson & Johnson
  • Mutual of America: Your Retirement Company